Langlade-Demoyen, P., F. Garcia-Pons, et al. Role of T cell help and endoplasmic
reticulum targeting in protective CTL response against influenza virus. Eur J
Immunol, v.33, n.3, Mar, p.720-8. 2003.
Latz, E., A. Schoenemeyer, et al. TLR9 signals after translocating from the ER to
CpG DNA in the lysosome. Nat Immunol, v.5, n.2, Feb, p.190-8. 2004.
Leutenegger, C. M., F. S. Boretti, et al. Immunization of cats against feline
immunodeficiency virus (FIV) infection by using minimalistic immunogenic
defined gene expression vector vaccines expressing FIV gp140 alone or with
feline interleukin-12 (IL-12), IL-16, or a CpG motif. J Virol, v.74, n.22, Nov,
p.10447-57. 2000.
Lima, K. M., S. A. Dos Santos, et al. Efficacy of DNA-hsp65 vaccination for
tuberculosis varies with method of DNA introduction in vivo. Vaccine, v.22, n.1,
Dec 8, p.49-56. 2003.
Lima, K. M., S. A. Santos, et al. Single dose of a vaccine based on DNA encoding
mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice
against a virulent strain of Mycobacterium tuberculosis. Gene Ther, v.10, n.8,
Apr, p.678-85. 2003.
Lin, S. J., C. D. Peacock, et al. Programmed death-1 (PD-1) defines a transient
and dysfunctional oligoclonal T cell population in acute homeostatic proliferation.
J Exp Med, v.204, n.10, Oct 1, p.2321-33. 2007.
Liu, M. A., B. Wahren, et al. DNA vaccines: recent developments and future
possibilities. Hum Gene Ther, v.17, n.11, Nov, p.1051-61. 2006.
Lowrie, D. B., C. L. Silva, et al. Protection against tuberculosis by a plasmid
DNA vaccine. Vaccine, v.15, n.8, Jun, p.834-8. 1997.
Lowrie, D. B., R. E. Tascon, et al. Therapy of tuberculosis in mice by DNA
vaccination. Nature, v.400, n.6741, Jul 15, p.269-71. 1999.